{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:08:16Z","timestamp":1791083296338,"version":"4.1.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3,15]]},"DOI":"10.1093\/cid\/cis989","type":"journal-article","created":{"date-parts":[[2012,12,9]],"date-time":"2012-12-09T02:05:29Z","timestamp":1355018729000},"page":"761-769","source":"Crossref","is-referenced-by-count":15,"title":["Antituberculosis Drug Resistance Acquired During Treatment: An Analysis of Cases Reported in California, 1994\u20132006"],"prefix":"10.1093","volume":"56","author":[{"given":"Travis C.","family":"Porco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Flood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,12,7]]},"reference":[{"key":"key\n\t\t\t\t20170623053516_CIS989C1","volume-title":"Multidrug and extensively drug-resistant TB (M\/XDR-TB): 2010 global report on surveillance and response","author":"World Health Organization","year":"2010"},{"key":"key\n\t\t\t\t20170623053516_CIS989C2","article-title":"Reported tuberculosis in the United States, 2009","author":"Centers for Disease Control and Prevention","year":"2010"},{"key":"key\n\t\t\t\t20170623053516_CIS989C3","article-title":"California Department of Public Health. Report on tuberculosis in California, 2009","author":"Westenhouse","year":"2010"},{"key":"key\n\t\t\t\t20170623053516_CIS989C4","volume-title":"Curry National Tuberculosis Center. Drug-resistant tuberculosis: a survival guide for clinicians.","author":"Francis","year":"2008","edition":"2nd ed"},{"key":"key\n\t\t\t\t20170623053516_CIS989C5","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1056\/NEJM199302253280802","article-title":"Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin","volume":"328","author":"Goble","year":"1993","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170623053516_CIS989C6","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1001\/jama.293.22.2732","article-title":"Multidrug resistance among persons with tuberculosis in California, 1994\u20132003","volume":"293","author":"Granich","year":"2005","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170623053516_CIS989C7","volume-title":"Extensively drug-resistant TB: CDC's public health response","author":"Gerberding","year":"2007"},{"key":"key\n\t\t\t\t20170623053516_CIS989C8","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1086\/590009","article-title":"Extensively drug-resistant tuberculosis in California, 1993\u20132006","volume":"47","author":"Banerjee","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170623053516_CIS989C9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1128\/AAC.46.2.267-274.2002","article-title":"Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective","volume":"46","author":"Gillespie","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170623053516_CIS989C10","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM199304223281601","article-title":"Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection","volume":"328","author":"Small","year":"1993","journal-title":"New Engl J Med"},{"key":"key\n\t\t\t\t20170623053516_CIS989C11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1473-3099(03)00483-3","article-title":"The effect of drug resistance on the fitness of Mycobacterium tuberculosis","volume":"3","author":"Cohen","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20170623053516_CIS989C12","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0140-6736(00)02429-6","article-title":"Classification of drug-resistant tuberculosis in an epidemic area","volume":"356","author":"Van Rie","year":"2000","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170623053516_CIS989C13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jinf.2005.10.002","article-title":"Drug-resistant tuberculosis: a disease of target populations in Houston, Texas","volume":"53","author":"El Sahly","year":"2006","journal-title":"J Infect"},{"key":"key\n\t\t\t\t20170623053516_CIS989C14","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0140-6736(96)03027-9","article-title":"The changing epidemiology of acquired drug-resistant tuberculosis in San Francisco, USA","volume":"348","author":"Bradford","year":"1996","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170623053516_CIS989C15","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1001\/jama.1997.03550100059039","article-title":"Trends in drug-resistant tuberculosis in the United States, 1993\u20131996","volume":"278","author":"Moore","year":"1997","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170623053516_CIS989C16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/(SICI)1097-0258(20000130)19:2<191::AID-SIM281>3.0.CO;2-Q","article-title":"A test for spatial disease clustering adjusted for multiple testing","volume":"19","author":"Tango","year":"2000","journal-title":"Stat Med"},{"key":"key\n\t\t\t\t20170623053516_CIS989C17","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1017\/S0950268804002869","article-title":"Explaining risk factors for drug-resistant tuberculosis in England and Wales: contribution of primary and secondary drug resistance","volume":"132","author":"Conaty","year":"2004","journal-title":"Epidemiol Infect"},{"key":"key\n\t\t\t\t20170623053516_CIS989C18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.7326\/0003-4819-149-2-200807150-00008","article-title":"Initial drug resistance and tuberculosis treatment outcomes: systematic review and meta-analysis","volume":"149","author":"Lew","year":"2008","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20170623053516_CIS989C19","first-page":"10","article-title":"How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis","volume":"2","author":"Mitchison","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"key":"key\n\t\t\t\t20170623053516_CIS989C20","first-page":"631","article-title":"Drug resistance among failure and relapse cases of tuberculosis: is the standard re-treatment regimen adequate?","volume":"7","author":"Quy","year":"2003","journal-title":"Int J Tuberc Lung Dis"},{"key":"key\n\t\t\t\t20170623053516_CIS989C21","first-page":"31","article-title":"Development of acquired drug resistance in recurrent tuberculosis patients with various previous treatment outcomes","volume":"8","author":"Yoshiyama","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"key\n\t\t\t\t20170623053516_CIS989C22","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1164\/ajrccm.153.2.8564140","article-title":"Independent origin of mono-rifampin-resistant Mycobacterium tuberculosis in patients with AIDS","volume":"153","author":"Lutfey","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20170623053516_CIS989C23","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1164\/ajrccm.157.6.9712009","article-title":"Risk factors for rifampin monoresistant tuberculosis","volume":"157","author":"Ridzon","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20170623053516_CIS989C24","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1086\/589240","article-title":"Human tuberculosis due to Mycobacterium bovis in the United States, 1995\u20132005","volume":"47","author":"Hlavsa","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170623053516_CIS989C25","first-page":"671","article-title":"Drug resistance pattern of Mycobacterium tuberculosis in a university hospital in Taiwan, 1998\u20132002","volume":"103","author":"Liaw","year":"2004","journal-title":"J Formos Med Assoc"},{"key":"key\n\t\t\t\t20170623053516_CIS989C26","first-page":"471","article-title":"Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results","volume":"73","author":"Fujino","year":"1998","journal-title":"Kekkaku"},{"key":"key\n\t\t\t\t20170623053516_CIS989C27","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1164\/rccm.200401-095OC","article-title":"Tuberculosis treatment outcomes: directly observed therapy compared with self-administered therapy","volume":"170","author":"Jasmer","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20170623053516_CIS989C28","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1086\/516146","article-title":"Rifampin-monoresistant tuberculosis in New York City, 1993\u20131994","volume":"25","author":"Munsiff","year":"1997","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170623053516_CIS989C29","first-page":"818","article-title":"Acquisition of drug resistance in multidrug-resistant Mycobacterium tuberculosis during directly observed empiric retreatment with standardized regimens","volume":"9","author":"Han","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"key":"key\n\t\t\t\t20170623053516_CIS989C30","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0035-9203(00)90205-0","article-title":"Tuberculosis treatment failure and drug resistance: same strain or reinfection?","volume":"94","author":"Sonnenberg","year":"2000","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key\n\t\t\t\t20170623053516_CIS989C31","first-page":"564","article-title":"Drug susceptibility testing of Mycobacterium tuberculosis: a neglected problem at the turn of the century","volume":"3","author":"Heifets","year":"1999","journal-title":"Int J Tuberc Lung Dis"},{"key":"key\n\t\t\t\t20170623053516_CIS989C32","first-page":"A3308","article-title":"Treatment practices, outcomes, and cost of multidrug-resistant and extensively drug resistant tuberculosis in the United States: preliminary results [abstract]","volume":"185","author":"Marks","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20170623053516_CIS989C33","article-title":"Tuberculosis stays in U.S. hospitals, 2006","author":"Holmquist"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/56\/6\/761\/17851750\/cis989.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T19:55:41Z","timestamp":1503431741000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/10.1093\/cid\/cis989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,7]]},"references-count":33,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2012,12,7]]},"published-print":{"date-parts":[[2013,3,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cis989","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12,7]]}}}